Ozone contributes to adapting to oxidative stress in respiratory diseases such as asthma, emphysema, and COPD. The primary challenges in the treatment of bronchial asthma include controlling infections, strengthening the immune system, addressing bronchial obstruction, managing allergic reactions, and addressing oxygen deficiency.
The development of pulmonary hypertension is also common in obstructive lung diseases. Asthma patients experiencing difficulty in breathing face issues such as decreased oxygen levels and increased carbon dioxide in the blood. Ozone not only eliminates infectious agents in these patients but also acts therapeutically by strengthening the immune system and oxygenating the blood with high energy. The vasodilatory effect of ozone leads to relaxation for these patients, increasing the oxygen-carrying capacity of the blood and addressing hypoxia in the tissues.
As a result of the effect of ozone on endothelial cells, bronchial spasm is resolved by the relaxation of smooth muscles. This leads to respiratory relief. Chronic bronchitis is one of the most common respiratory diseases, and ozone therapy strengthens the diminished local and general defense mechanisms in this condition. An increase in T lymphocytes and T helper cells results in elevated levels of immunoglobulins Ig A and Ig M in the serum.
The circulation of immune complexes increases, and phagocytic neutrophils become activated. Inflammation of the bronchi decreases, resulting in respiratory relief and a decrease in mucus production. As a result of Antalya Ozone therapy, patients experience a rapid improvement in sensations of suffocation and difficulty breathing. Furthermore, the dosage of medications they typically need to use decreases. Scientific studies have shown that the dosage of medications used by asthmatic patients has decreased by more than 50% in 65% of cases.
